Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the wanecam 1 data from bobo-dioulasso, burkina faso

HIGHLIGHTS

  • who: Yves Daniel Compaoré from the Institut de Recherche en Sciences de la Santé, Direction Régionale de have published the paper: Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso, in the Journal: (JOURNAL) of August/22,/2012
  • what: Since efficacy of these 4 artemisinin-based combinations in the context of this clinical trial has already been reported , this work aims to evaluate specifically the hepatic safety of repeated treatment with pyronaridineartesunate versus artemether . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?